RehabCare Leverages Force.com Platform to Build Custom Healthcare Application for use on Ap...(ic statements are not currently availabl...),Health
Navigation Links
RehabCare Leverages Force.com Platform to Build Custom Healthcare Application for use on Apple iPhone
Date:5/26/2009
ic statements are not currently available and may not be delivered on time or at all. Customers who purchase salesforce.com applications should make their purchase decisions based upon features that are currently available. Salesforce.com has headquarters in San Francisco, with offices in Europe and Asia, and trades on the New York Stock Exchange under the ticker symbol "CRM". For more information please visit http://www.salesforce.com, or call 1-800-NO-SOFTWARE.
Copyright (c) 2009 salesforce.com, inc. All rights reserved. Salesforce and the "no software" logo are registered trademarks of salesforce.com, inc., and salesforce.com owns other registered and unregistered trademarks. Other names used herein may be trademarks of their respective owners.
'/>"/>
| SOURCE salesforce.com Copyright©2009 PR Newswire. All rights reserved |
Related medicine news :
1. Wellmark Leverages MDdatacor Technology to Streamline Immunization Tracking
2. Physicians Choice Leverages InstaMeds Integrated Platform for Healthcare Payment & Clearinghouse Solutions
3. Kings Daughters Medical Center Leverages Unique Bedside Interactive Technology to Meet Requirements of Patient Safety Goal 16
4. Pacira Pharmaceuticals Leverages TalentManager(R) from Salary.Com(TM) to Integrate Compensation and Performance Management Processes
5. Insurance Giant Leverages Technology to Enhance Offerings
6. Renowned Leader and Educator in Robotic Cardiac Bypass Surgery Leverages Cardicas C-Port(R) Flex-A(R) Anastomosis System in His Practice and to Educate Cardiothoracic Surgeons
7. TCS Healthcare Technologies to Offer Interactive Text Messaging As Part of Its Care Management Software Platform
8. 403(b) Administration Now Turn-Key with New 'Single Solution/Multi-Provider' Web Hosted Platform - 403(b)connect
9. StreetWise HSA(SM) Launched Nationally: First Low-Cost, Customizable Platform for Employee HSA Education
10. Dictation, Transcription Workflow and Document Management Platform Aids Physicians In Searching For Swine Flu Symptoms
11. Administrative Advantage Selects ZyDoc e-Transcription Platform for Clients
Post Your Comments:
(Date:12/5/2009)... significant scientific advances in the field of blood cancers, ... of how certain diseases progress in order to discover ... care. Research presented today at the 51st Annual Meeting ... therapies for managing multiple myeloma, the importance of advance ...
(Date:12/5/2009)... triggers, experts advise , , SATURDAY, Dec. 5 (HealthDay News) ... asthma can have bad reactions to certain holiday traditions ... and wheezing, according to the American College of Allergy, ... to live evergreens may choose to decorate with artificial ...
(Date:12/5/2009)... are popping up in the most unusual places, and to do everything ... ... (PRWEB) December 5, 2009 -- Who would have thought that your wine, ... Fort Worth, Texas has announced a new line of turbines, for industry ...
(Date:12/4/2009)... Holdings, Ltd (NYSE: AWH ) today announced ... Sennott, Executive Vice,President and Chief Corporate Strategy Officer, will ... Conference being held at the Goldman,Sachs Conference Center in ... About Allied World Assurance Company ...
(Date:12/4/2009)... Calif., Dec. 4 Pamela Bowen, Chief Information Officer ... the "Chief Innovation Officer" Appy Award for transforming Crescent,s ... recipients are nominated based on their innovative usage of ... levels of customer success to their sales, marketing, partner, ...
Breaking Medicine News(10 mins):Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 2Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 3Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 4Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 5Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 6Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 7Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 8Health News:Keep Asthma, Allergies at Bay for the Holidays 2Health News:Distributor Announces New Applications for Wind Turbines 2Health News:Distributor Announces New Applications for Wind Turbines 3Health News:Allied World to Present at the 2009 Goldman Sachs U.S. Financial Services Conference 2Health News:Crescent CIO '09 Dreamforce Conference Speaker and Award Finalist 2[0] New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer[0] Keep Asthma, Allergies at Bay for the Holidays[0] Distributor Announces New Applications for Wind Turbines [0] Allied World to Present at the 2009 Goldman Sachs U.S. Financial Services Conference[0] Crescent CIO '09 Dreamforce Conference Speaker and Award Finalist
... help keep extra pounds at bay, expert says , SUNDAY, Dec. ... of the holidays, it,s all too easy to pack on extra ... bit of planning may help you avoid weight gain, says Jennifer ... University. , "It,s OK to indulge in a little of your ...
... U2,s Bono and Others Challenge 5,000 Teens via, Simulcast to 200 Locations ... ... Cure, LAKE FOREST, Calif., Dec. 1 First ... Church, held on World AIDS Day, which capped a,four-day Global Summit on AIDS ...
... Everything from Christmas trees to fake snow can trigger symptoms, ... It,s easy for the holidays to become the season ... or other allergies and asthma, say experts at the American ... preventive measures can cut symptoms to a minimum, they say. ...
... Children Living with HIV Stand to Benefit from ... ... made its new,lower- strength lopinavir/ritonavir (LPV/r) tablet, known as Aluvia(R) in,developing ... in Uganda -- a step the company hopes will,begin to improve ...
... VA As the obesity epidemic grows in ... far reaching health concerns for overweight children. Sleep-disordered ... ranging in severity from snoring to obstructive sleep ... and African- American, according to a new study ...
... Awareness of Disease, Funding for Research, SAN JOSE, Calif., ... death defying stunts and his recovery from,life threatening injuries due ... life was one that has no treatment and no cure. ... will lose their,lives to idiopathic pulmonary fibrosis (IPF) this year, ...
Other Medicine News:Health News:Holidays Don't Have to Leave You Heavier 2Health News:First-Ever Saddleback AIDS Youth Summit Addresses a Future Without HIV On World Aids Day: 2Health News:First-Ever Saddleback AIDS Youth Summit Addresses a Future Without HIV On World Aids Day: 3Health News:'Tis the Season For Allergy, Asthma 2Health News:Ugandan Children Are Among the First to Receive Abbott's Lower-Strength Aluvia (lopinavir/ritonavir) Tablet 2Health News:Ugandan Children Are Among the First to Receive Abbott's Lower-Strength Aluvia (lopinavir/ritonavir) Tablet 3Health News:Ugandan Children Are Among the First to Receive Abbott's Lower-Strength Aluvia (lopinavir/ritonavir) Tablet 4Health News:Ugandan Children Are Among the First to Receive Abbott's Lower-Strength Aluvia (lopinavir/ritonavir) Tablet 5Health News:Ugandan Children Are Among the First to Receive Abbott's Lower-Strength Aluvia (lopinavir/ritonavir) Tablet 6Health News:Ugandan Children Are Among the First to Receive Abbott's Lower-Strength Aluvia (lopinavir/ritonavir) Tablet 7Health News:Ugandan Children Are Among the First to Receive Abbott's Lower-Strength Aluvia (lopinavir/ritonavir) Tablet 8Health News:Childhood sleep-disordered breathing disproportionately affects obese and African-Americans 2Health News:Evel Knievel Lost to Pulmonary Fibrosis; Disease Claims as Many Lives as Breast Cancer Each Year 2Holidays Don't Have to Leave You HeavierFirst-Ever Saddleback AIDS Youth Summit Addresses a Future Without HIV On World Aids Day:'Tis the Season For Allergy, AsthmaUgandan Children Are Among the First to Receive Abbott's Lower-Strength Aluvia (lopinavir/ritonavir) TabletChildhood sleep-disordered breathing disproportionately affects obese and African-AmericansEvel Knievel Lost to Pulmonary Fibrosis; Disease Claims as Many Lives as Breast Cancer Each Year
(Date:12/4/2009)... Imaging, LLC, an independent provider of CT, MRI ... and healthcare providers, is excited to announce it ... Health Care, a nationally-recognized, prestigious gold seal of ... Shared Imaging accreditation is system-wide for its mobile ...
(Date:12/4/2009)... Hospira, Inc. (NYSE: HSP ), a leading ... the launch of its next-generation 50 mL and 100 ... and now offers a complete size range (50 mL ... product. The launch of the 50 mL and 100 ...
(Date:12/4/2009)... Suneva Medical, a privately-held aesthetic medical device company, ... President and Chief Financial Officer. In this role, ... administrative functions including finance, accounting, IT, IR, administration and ... Company,s senior management team. ,, "One of my ...
Breaking Medicine Technology:Shared Imaging Earns The Joint Commission's Accreditation for Ambulatory Health Care 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 3Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 4Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 2Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 3Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 4eCube Delivers Linux on System z Support for NXTera High Performance Middleware 62413 1eCube Delivers Linux on System z Support for NXTera High Performance Middleware 62413 2eCube Delivers Linux on System z Support for NXTera High Performance Middleware 62413 3Outpatient Disc Treatment Gives Long Term Back Pain Relief 62408 1Outpatient Disc Treatment Gives Long Term Back Pain Relief 62408 2Outpatient Disc Treatment Gives Long Term Back Pain Relief 62408 3AMT Announces Management Changes in Light of Refocused Strategy 6665 1AMT Announces Management Changes in Light of Refocused Strategy 6665 2AMT Announces Management Changes in Light of Refocused Strategy 6665 3[0] Shared Imaging Earns The Joint Commission's Accreditation for Ambulatory Health Care[0] Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers[0] Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer
... Cougar Biotechnology,Inc. (OTCBB:CGRB) today announced that positive Phase ... cancer drug candidate CB7630,(abiraterone acetate) was presented at ... currently taking place,in Anaheim, California. The data was ... Research UK Centre for Cancer Therapeutics at,The Institute ...
... WIRE)--May 21, 2007 - Medical,professionals seeking to ... gram-negative pneumonia may have a new weapon:,NKTR-061 ... by Nektar Therapeutics (Nasdaq:NKTR)., Results of a ... of,NKTR-061 (Inhaled Amikacin) to treat mechanically ventilated,patients ...
Other Medicine Technology:Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at AUA Annual Meeting 2Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at AUA Annual Meeting 3Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at AUA Annual Meeting 4Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 2Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 3Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 4Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 5Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 6Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 7Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 8Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 9Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 10Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 11Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at AUA Annual MeetingNektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products:| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |